tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CADL Stock Latest News

Candel Therapeutics Elects New Directors at Annual Meeting
Company AnnouncementsCandel Therapeutics Elects New Directors at Annual Meeting
10h ago
8K
CADL
Promising Potential of Candel Therapeutics in Prostate Cancer Treatment: A High-Risk, High-Reward Investment Opportunity
PremiumRatings
Promising Potential of Candel Therapeutics in Prostate Cancer Treatment: A High-Risk, High-Reward Investment Opportunity
6d ago
CADL
Candel Therapeutics Appoints New Board Member
PremiumCompany Announcements
Candel Therapeutics Appoints New Board Member
12d ago
8K
CADL
Candel Therapeutics appoints Radhakrishnan to board of directors
PremiumThe Fly
Candel Therapeutics appoints Radhakrishnan to board of directors
12d ago
CADL
Candel Therapeutics’ CAN-2409: Promising Phase 3 Results and Buy Rating for Prostate Cancer Treatment
PremiumRatings
Candel Therapeutics’ CAN-2409: Promising Phase 3 Results and Buy Rating for Prostate Cancer Treatment
15d ago
CADL
Buy Recommendation for Candel Therapeutics: Promising Data on CAN-2409 Treatment for Prostate Cancer
PremiumRatingsBuy Recommendation for Candel Therapeutics: Promising Data on CAN-2409 Treatment for Prostate Cancer
15d ago
CADL
Candel Therapeutics to hold a conference call
Premium
The Fly
Candel Therapeutics to hold a conference call
15d ago
CADL
Candel Therapeutics Receives FDA RMAT Designation for CAN-2409
Premium
Company Announcements
Candel Therapeutics Receives FDA RMAT Designation for CAN-2409
21d ago
8K
CADL
Candel Therapeutics receives FDA RMAT designation to CAN-2409
PremiumThe Fly
Candel Therapeutics receives FDA RMAT designation to CAN-2409
21d ago
CADL
Candel Therapeutics to host investor call on CAN-2409 Phase 3 data
PremiumThe Fly
Candel Therapeutics to host investor call on CAN-2409 Phase 3 data
22d ago
CADL
Candel Therapeutics Unveils Promising Phase 3 Trial Results
PremiumCompany Announcements
Candel Therapeutics Unveils Promising Phase 3 Trial Results
27d ago
8K
CADL
Promising Pipeline Developments and Strong Data Support Buy Rating for Candel Therapeutics
PremiumRatings
Promising Pipeline Developments and Strong Data Support Buy Rating for Candel Therapeutics
1M ago
CADL
Candel Therapeutics Reports Strong Q1 2025 Results
PremiumCompany AnnouncementsCandel Therapeutics Reports Strong Q1 2025 Results
1M ago
CADL
Candel Therapeutics reports Q1 EPS 13c vs. (28c) last year
Premium
The Fly
Candel Therapeutics reports Q1 EPS 13c vs. (28c) last year
1M ago
CADL
Candel Therapeutics sees cash runway into 1Q27
Premium
The Fly
Candel Therapeutics sees cash runway into 1Q27
1M ago
CADL
Candel Therapeutics’ CAN-2409 Trial Results Accepted at ASCO
PremiumCompany Announcements
Candel Therapeutics’ CAN-2409 Trial Results Accepted at ASCO
2M ago
8K
CADL
Promising Clinical Outcomes and Strategic Advances Boost Candel Therapeutics’ CAN-2409 Potential in Oncology
PremiumRatings
Promising Clinical Outcomes and Strategic Advances Boost Candel Therapeutics’ CAN-2409 Potential in Oncology
2M ago
CADL
Candel Therapeutics announces publication of Phase 1b trial data on CAN-2409
PremiumThe Fly
Candel Therapeutics announces publication of Phase 1b trial data on CAN-2409
3M ago
CADL
Promising Survival Data and Strategic Partnerships Drive Buy Rating for Candel Therapeutics
PremiumRatings
Promising Survival Data and Strategic Partnerships Drive Buy Rating for Candel Therapeutics
3M ago
CADL
Promising CAN-2409 Trial Results Drive Buy Rating for Candel Therapeutics
PremiumRatingsPromising CAN-2409 Trial Results Drive Buy Rating for Candel Therapeutics
3M ago
CADL
Candel Therapeutics Reports Positive Phase 2a Trial Results
Premium
Company Announcements
Candel Therapeutics Reports Positive Phase 2a Trial Results
3M ago
8K
CADL
Candel Therapeutics announces final survival data from CAN-2409 trial
Premium
The Fly
Candel Therapeutics announces final survival data from CAN-2409 trial
3M ago
CADL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >